Correlation Between Enanta Pharmaceuticals and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Scpharmaceuticals, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Scpharmaceuticals.
Diversification Opportunities for Enanta Pharmaceuticals and Scpharmaceuticals
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enanta and Scpharmaceuticals is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Scpharmaceuticals
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 0.94 times more return on investment than Scpharmaceuticals. However, Enanta Pharmaceuticals is 1.07 times less risky than Scpharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 894.00 in Enanta Pharmaceuticals on September 12, 2024 and sell it today you would lose (194.00) from holding Enanta Pharmaceuticals or give up 21.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Scpharmaceuticals
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Scpharmaceuticals |
Enanta Pharmaceuticals and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Scpharmaceuticals
The main advantage of trading using opposite Enanta Pharmaceuticals and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |